XML 54 R34.htm IDEA: XBRL DOCUMENT
v3.25.4

Description of the Company and Summary of Significant Accounting Policies (Tables) | 12 Months Ended
--- | ---
Dec. 28, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Trade Receivable and Allowance for Credit Losses | The following table summarizes the activity related to the allowance for credit losses during the fiscal twelve months ended December 28, 2025, December 29, 2024, and December 31, 2023:
|  | Fiscal Twelve Months Ended
(Dollars in Millions) |  | December 28, 2025 |  | December 29, 2024 |  | December 31, 2023
Allowance for credit losses, beginning of fiscal year |  | $ | (26) |  |  | $ | (25) |  |  | $ | (35) |
Provision |  | (11) |  |  | (6) |  |  | (4) |
Utilization |  | 12 |  |  | 4 |  |  | 14 |
Currency translation |  | (1) |  |  | 1 |  |  | — |
Allowance for credit losses, end of fiscal year |  | $ | (26) |  |  | $ | (26) |  |  | $ | (25) |
Property, Plant and Equipment | Property, plant, and equipment are stated at cost less accumulated depreciation. The Company utilizes the straight-line method of depreciation over the estimated useful lives. The following table summarizes the approximate ranges for estimated useful lives as of December 28, 2025:
Machinery and equipment |  | 2 – 13 years
Buildings and building equipment |  | 20 – 40 years
Software |  | 3 – 15 years
Land improvements |  | 10 – 20 years
As of December 28, 2025 and December 29, 2024, property, plant, and equipment at cost and the related accumulated depreciation were:
(Dollars in Millions) |  | December 28, 2025 |  | December 29, 2024
Machinery and equipment |  | $ | 2,496 |  |  | $ | 2,250 |
Buildings and building equipment |  | 1,853 |  |  | 1,599 |
Software |  | 227 |  |  | 102 |
Construction in progress |  | 595 |  |  | 542 |
Land and land improvements |  | 60 |  |  | 57 |
Total property, plant, and equipment, gross |  | 5,231 |  |  | 4,550 |
Less: accumulated depreciation |  | (3,019) |  |  | (2,701) |
Total property, plant, and equipment, net(1) |  | $ | 2,212 |  |  | $ | 1,849 |
(1) As of December 29, 2024, the Consolidated Balance Sheet reflects an adjustment for a change in classification from Property, plant, and equipment, net of $288 million to Other assets and Additional paid-in capital of $169 million and $84 million, respectively, related to certain cloud computing arrangements, net of amortization of $35 million. The Company concluded that this adjustment was not material to the Consolidated Financial Statements for the prior period. Depreciation expense for the fiscal twelve months ended December 28, 2025, December 29, 2024, and December 31, 2023 was as follows:
|  | Fiscal Twelve Months Ended
(Dollars in Millions) |  | December 28, 2025 |  | December 29, 2024 |  | December 31, 2023
Depreciation expense(1) |  | $ | 300 |  |  | $ | 353 |  |  | $ | 305 |
(1) Depreciation for the fiscal twelve months ended December 28, 2025 and December 29, 2024 includes $99 million and $145 million, respectively, of amortization of integration and development costs capitalized in connection with cloud computing arrangements, as discussed in “—Cloud Computing Arrangements” above. See “—Property, Plant, and Equipment” above for information related to cloud computing arrangements for the fiscal twelve months ended December 31, 2023.
Details of Impairment of Long-Lived Assets by Asset | Impairment charges for the fiscal twelve months ended December 28, 2025 and December 29, 2024 consisted of:
|  |  |  | Fiscal Twelve Months Ended
(Dollars in Millions) |  |  |  |  |  | December 28, 2025 |  | December 29, 2024 |  |
Dr.Ci:Labo® asset impairment(1) |  |  |  |  |  | $ | — |  |  | $ | 488 |  |  |
Skillman fixed asset impairment(2) |  |  |  |  |  | — |  |  | 68 |  |  |
Other asset impairment(3) |  |  |  |  |  | 23 |  |  | 22 |  |  |
Total impairment charges |  |  |  |  |  | $ | 23 |  |  | $ | 578 |  |  |
(1) Represents the impairment charge recognized during the fiscal three months ended June 30, 2024 in relation to Dr.Ci:Labo® long-lived assets. See “—Dr.Ci:Labo® Asset Impairment” below and Note 4, “Intangible Assets and Goodwill,” for more information. (2) Represents the impairment charge recorded during the fiscal three months ended March 31, 2024 on the held for sale asset associated with the Company’s former corporate headquarters in Skillman, New Jersey. See “—Assets Held for Sale” below. (3) Represents the impairment charge recognized during the fiscal three months ended December 28, 2025 related to the ORSL® trade name following regulatory changes in India and the impairment charge recognized during the fiscal three months ended June 30, 2024 related to certain software development assets.
Schedule Of Separation Related Costs | Separation-related costs for the fiscal twelve months ended December 28, 2025, December 29, 2024, and December 31, 2023 consisted of:
|  |  |  | Fiscal Twelve Months Ended
(Dollars in Millions) |  |  |  |  |  | December 28, 2025 |  | December 29, 2024 |  | December 31, 2023
Information technology and other(1) |  |  |  |  |  | $ | 68 |  |  | $ | 255 |  |  | $ | 468 |
Legal entity name change |  |  |  |  |  | 20 |  |  | 41 |  |  | — |
Total Separation-related costs |  |  |  |  |  | $ | 88 |  |  | $ | 296 |  |  | $ | 468 |
(1) Primarily related to the disentanglement of systems and the costs associated with the discontinuation of certain information technology assets. These costs also include depreciation expense on Separation-related assets for the fiscal twelve months ended December 29, 2024.
Supplier Finance Program | The following table summarizes the changes in the Company’s outstanding obligations confirmed as valid under its supplier finance program during the fiscal twelve months ended December 28, 2025 and December 29, 2024:
(Dollars in Millions) |  | December 28, 2025 |  | December 29, 2024
Confirmed obligations outstanding at the beginning of the fiscal year |  | $ | 260 |  |  | $ | 227 |
Invoices confirmed during the fiscal year |  | 1,152 |  |  | 1,093 |
Confirmed invoices paid during the fiscal year |  | (1,098) |  |  | (1,060) |
Confirmed obligations outstanding at the end of the fiscal year |  | $ | 314 |  |  | $ | 260 |
Schedule of Variable Interest Entities | All Deferred Legal Entities were exposed to similar operational risks and were therefore monitored and evaluated on a similar basis by management. Accordingly, the financial information for Deferred Legal Entities has been aggregated and the following table summarizes the consolidated assets and liabilities of these entities on the Consolidated Balance Sheet as of December 29, 2024. The amounts represented in this table are only those assets of the VIEs that could be used to settle only the VIE’s obligations and the VIE’s creditors (or beneficial interest holders) had no recourse against the general credit of the primary beneficiary.
(Dollars in Millions) |  |  |  |  |  |  |  | December 29, 2024
Assets |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  |  |  |  |  |  |  | $ | 99 |
Trade receivables, less allowances for credit losses |  |  |  |  |  |  |  | 70 |
Inventories |  |  |  |  |  |  |  | 16 |
Prepaid expenses and other receivables |  |  |  |  |  |  |  | 3 |
Total current assets |  |  |  |  |  |  |  | 188 |
Property, plant, and equipment, net |  |  |  |  |  |  |  | 3 |
Deferred taxes on income |  |  |  |  |  |  |  | 3 |
Total assets |  |  |  |  |  |  |  | $ | 194 |
Liabilities |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Accounts payable |  |  |  |  |  |  |  | $ | 3 |
Accrued liabilities |  |  |  |  |  |  |  | 11 |
Accrued rebates, returns, and promotions |  |  |  |  |  |  |  | 16 |
Total current liabilities |  |  |  |  |  |  |  | 30 |
Total liabilities |  |  |  |  |  |  |  | $ | 30 |

X
- Definition Details of Impairment of Long-Lived Assets by Asset + References No definition available. + Details
Name: | kvue_DetailsOfImpairmentOfLongLivedAssetsByAssetTableTextBlock
Namespace Prefix: | kvue_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Separation Related Costs + References No definition available. + Details
Name: | kvue_ScheduleOfSeparationRelatedCostsTableTextBlock
Namespace Prefix: | kvue_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allowance for credit loss on accounts receivable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 + Details
Name: | us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1 + Details
Name: | us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-9 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-6 + Details
Name: | us-gaap_ScheduleOfVariableInterestEntitiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of supplier finance program. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 405 -SubTopic 50 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 405 -SubTopic 50 -Name Accounting Standards Codification -Section 55 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477128/405-50-55-5 + Details
Name: | us-gaap_SupplierFinanceProgramTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration